Q32 Bio Inc.QTTBNASDAQ
Loading
QTTB Revenue Growth (YoY Quarterly)•+0.00%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+0.00%
+0.0pp
+0.00%
+0.0pp
+583.84%
+583.8pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+3.00%
+1.6pp
+3.24%
+1.9pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | -680.53% | +0.00% | +0.00% | +583.84% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | -1172.01% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | -1142.87% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | -1142.87% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +278.43% | +2.14% | +1.95% | +1.36% | +3.00% |
| Weighted Average Shares Diluted Growth | +278.43% | +2.14% | +1.95% | +1.36% | +3.24% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -26.49% | -1.42% | -1.42% | -100.00% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +96.21% | -48.09% | -46.77% | -44.73% | -33.09% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +618.79% |
| Debt Growth | -62.82% | -6.69% | -5.82% | -41.55% | -40.86% |
| R&D Expense Growth | +26.45% | -27.61% | -61.52% | -75.22% | -68.56% |
| SG&A Expenses Growth | +41.77% | +4.61% | -8.59% | -9.98% | +14.12% |
1 / 4